Viewing Study NCT04629794


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2025-12-26 @ 12:06 AM
Study NCT ID: NCT04629794
Status: UNKNOWN
Last Update Posted: 2023-04-04
First Post: 2020-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The OsteoStrand Plus Deformity Study
Sponsor: SeaSpine, Inc.
Organization:

Study Overview

Official Title: The OsteoStrand Plus Deformity Study
Status: UNKNOWN
Status Verified Date: 2023-03
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A clinical study evaluating outcomes for patients with spinal deformity.
Detailed Description: A clinical study evaluating deformity patients treated with Demineralized Bone Matrix as compared to patients treated with Bone Morphogenetic Protein.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: